News About: Pharm. Industry
DaewoongBio eyes markets of finished pharmaceuticals
DaewoongBio, a local maker for pharmaceutical raw materials, seeks to take the lead in the domestic and overseas market by launching a new drug business unit, a company official said on April 19.
The business unit ...
Chong Kun Dang fosters ‘green management’ culture
Chong Kun Dang Pharmaceutical Co., the nation’s leading drug manufacturer, is taking the lead in local firms’ green drive by launching a green pharma campaign.
In a recent forum, the company said it saved a total o...
Choong-wae announces development of anticancer agent to kill leukemia stem cells
Choong-wae Pharm announced on April 19 the development of an anti-cancer medicine that interrupts biochemical signals to eradicate leukemia stem cells without affecting normal cells.
Speaking at a seminar at the Am...
Samjin looks to newly emerging appetite stimulant market
Samjin Pharm said the annual revenue of its OTC appetite stimulant drug “Trestan” will reach 10 billion won, thanks much to increasing market demand.
“The domestic market for appetite-stimulating pharmaceuticals, w...
Who will head Korea Pharmaceutical Manufacturers Association?
The Korea Pharmaceutical Manufacturers Association, a leading business lobby, says it will appoint a new president and executives from the outside until the middle of next month.
The organization said it has contac...
Government to withhold corporate tax cut
The government is considering withholding or scrapping tax cut programs for facility investment, which will affect some drug makers who have an intention of reconstructing their cGMP plants.
So far, companies have ...
Green Cross seeking to go global with flu vaccine
Green Cross Corporation said on April 20 that the company is set to export $6 million won worth of Influenza A (H1N1) flu vaccines to the World Health Organization (WHO).
Last September, Green Cross has submitted a...
Debate is getting heated on government’s drug pricing reform
Doctors and pharmacists are vigorously opposed to the government’s anti-rebate measures to bring criminal charges against rebate-taking doctors and pharmacists.
They have threatened to boycott the new drug pricing ...
Korea’s leading drug manufacturers suffer setback due to inactive marketing activities in March
Multinational drug manufacturers are smiling while their Korean counterparts are grimacing after sales of prescription drugs in March were unveiled.
The nation’s prescription market volume in March posted 814.6 bi...
Ilyang to conduct Phase 2 study of new leukemia dug in India, Thailand
Ilyang Pharm said on April 15 that it will soon begin Phase II clinical trial for its new leukemia drug in India and Thailand.
Developed by Ilyang, the drug is believed to be 30 times more potent than Glivec, a pop...
